Active	Status	Sponsor type	Region	Phase	Filter
11 Active 52 Inactive 63 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lipton, Richard B
NCT04845178: Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in Adults	Completed	2	797	NA	ABP-450, prabotulinumtoxinA, Placebo, 0.9% sodium chloride, saline	AEON Biopharma, Inc., PPD	Migraine	06/24	08/24
NCT05016661: Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention	Terminated	2	466	Canada, US, RoW	ABP-450, prabotulinumtoxinA	AEON Biopharma, Inc., PPD DEVELOPMENT, LP	Migraine	07/24	08/24
Kearns, Marie
No trials found
Goldstein, Stephanie
No trials found
Siket, Matthew
No trials found